Explainability for artificial intelligence in healthcare: a multidisciplinary perspective J Amann, A Blasimme, E Vayena, D Frey, VI Madai, ... BMC medical informatics and decision making 20, 1-9, 2020 | 895 | 2020 |
Machine learning in medicine: addressing ethical challenges E Vayena, A Blasimme, IG Cohen PLoS medicine 15 (11), e1002689, 2018 | 554 | 2018 |
Digital health: meeting the ethical and policy challenges E Vayena, T Haeusermann, A Adjekum, A Blasimme Swiss medical weekly 148, w14571, 2018 | 180 | 2018 |
Elements of trust in digital health systems: scoping review A Adjekum, A Blasimme, E Vayena Journal of medical Internet research 20 (12), e11254, 2018 | 135 | 2018 |
Operational definition of active and healthy ageing (AHA): a conceptual framework J Bousquet, D Kuh, M Bewick, T Standberg, J Farrell, R Pengelly, ME Joel, ... The journal of nutrition, health & aging 19, 955-960, 2015 | 130 | 2015 |
Biomedical big data: new models of control over access, use and governance E Vayena, A Blasimme Journal of bioethical inquiry 14, 501-513, 2017 | 127 | 2017 |
Health research with big data: time for systemic oversight E Vayena, A Blasimme The journal of law, medicine & ethics 46 (1), 119-129, 2018 | 117 | 2018 |
Mapping the translational science policy ‘valley of death’ EM Meslin, A Blasimme, A Cambon-Thomsen Clinical and translational medicine 2, 1-8, 2013 | 96 | 2013 |
Data sharing for precision medicine: policy lessons and future directions A Blasimme, M Fadda, M Schneider, E Vayena Health Affairs 37 (5), 702-709, 2018 | 93 | 2018 |
What's next for COVID-19 apps? Governance and oversight A Blasimme, E Vayena Science 370 (6518), 760-762, 2020 | 84 | 2020 |
Open sharing of genomic data: Who does it and why? T Haeusermann, B Greshake, A Blasimme, D Irdam, M Richards, ... PLoS One 12 (5), e0177158, 2017 | 79 | 2017 |
Cell reprogramming requires silencing of a core subset of polycomb targets G Fragola, PL Germain, P Laise, A Cuomo, A Blasimme, F Gross, ... PLoS genetics 9 (2), e1003292, 2013 | 78 | 2013 |
Ethics review of big data research: What should stay and what should be reformed? A Ferretti, M Ienca, M Sheehan, A Blasimme, ES Dove, B Farsides, ... BMC medical ethics 22 (1), 51, 2021 | 66 | 2021 |
Big data and dementia: charting the route ahead for research, ethics, and policy M Ienca, E Vayena, A Blasimme Frontiers in medicine 5, 13, 2018 | 65 | 2018 |
Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine A Blasimme, E Vayena BMC Medical Ethics 17 (67), 2016 | 64 | 2016 |
Digital contact tracing against COVID-19 in Europe: current features and ongoing developments A Blasimme, A Ferretti, E Vayena Frontiers in Digital Health 3, 660823, 2021 | 63 | 2021 |
Operational definition of active and healthy aging (AHA): the European innovation partnership (EIP) on AHA reference site questionnaire: Montpellier October 20–21, 2014, Lisbon … J Bousquet, J Malva, M Nogues, LR Mañas, B Vellas, J Farrell, M Bewick, ... Journal of the American Medical Directors Association 16 (12), 1020-1026, 2015 | 62 | 2015 |
Familial Alzheimer's disease sustained by presenilin 2 mutations: Systematic review of literature and genotype–phenotype correlation M Canevelli, P Piscopo, G Talarico, N Vanacore, A Blasimme, A Crestini, ... Neuroscience & Biobehavioral Reviews 42, 170-179, 2014 | 57 | 2014 |
The ethics of AI in biomedical research, patient care and public health A Blasimme, E Vayena Patient Care and Public Health (April 9, 2019). Oxford Handbook of Ethics of …, 2019 | 54 | 2019 |
Democratizing health research through data cooperatives A Blasimme, E Vayena, E Hafen Philosophy & Technology 31, 473-479, 2018 | 50 | 2018 |